Safety Diagnostics for Dose-Escalation Trial Designs
Enhances various R packages that support the design and simulation of phase 1 dose-escalation trials, adding diagnostics to examine the safety characteristics of these designs in light of expected inter-individual variation in pharmacokinetics and pharmacodynamics. See Norris (2020b), "Retrospective analysis of a fatal dose-finding trial" <arXiv:2004.12755> and (2020c) "What Were They Thinking? Pharmacologic priors implicit in a choice of 3+3 dose-escalation design" <arXiv:2012.05301>.
Please choose more modern alternatives, such as Google Chrome or Mozilla Firefox.